GALILEO LIFE SCIENCES INC (OTC: "MDRM") Continues Development of Its Telehealth Business Model And Announces an Opening Date for Its "VCPlus Clinics" in October 2021
07 October 2021 - 10:00PM
InvestorsHub NewsWire
TORONTO, ONTARIO, Canada -- October 7, 2021 -- InvestorsHub
NewsWire -- Galileo Life Sciences Inc (OTC: MDRM), also known as Modern Mobility Aids,
(The Company) is a Nevada-based company, whose strategic focus lies
in launching an innovative telehealth platform. The first of its
"Virtual-Care-Plus" (VCPlus) clinics is scheduled to open on
October 17, 2021. The clinic is located within Nanaksar Pharmacy
(Nanaksar) in Brampton, Ontario.
By the end of October 2021, two more VCPlus clinics will be open
at (i) Guardian MarkhaMack Pharmacy located in Markham, Ontario and
(ii) in the Four Winds Roots Pharmacy in North York, Ontario.
To finalize this initiative, the Company has recruited several
licensed primary care physicians to provide telehealth
consultations and treat patients attending the clinics.
"We are excited to launch our first three clinics. The concept
of VCPlus clinics is what differentiates us from our competitors
and other telehealth providers as our physicians will be able to
virtually check patients' vitals in real time, without affecting
the quality of care." said Tito DiMarco, President and CEO of
Galileo Life Sciences Inc.
The company will be using secure technology provided by AMD
Global Telemedicine (AMD) to
deliver the best possible solution for patients attending the
clinics. Galileo will also offer "House Calls" for patients who are
unable to attend a physical VCPlus location. This will involve a
technician bringing the VCPlus directly to the patient's home for a
truly virtual doctor's visit.
COVID-19 has changed the way the world looks at healthcare in
all aspects, from the importance of getting regular health checkups
to establishing a primary network of care. Along with other
factors, the growth in population also reinforces the need for
healthcare that is reliable and attainable, not sacrificing
either.
Telehealth services are one of the primary sources of healthcare
for people living in areas where physical healthcare may be
inaccessible or overpriced. Globally, technological innovation is
impacting all industries and disrupting processes to lead to a
constructive solution that will greatly benefit the public. When it
comes to online consultation services and being able to access
quality healthcare, the narrative is quickly changing to a positive
one due to the benefits these services are able to provide.
COVID-19 has changed the way the world looks at healthcare in all
aspects, from the importance of getting regular health checkups to
establishing a primary network of care.
The global telehealth market is expected to increase from $90
billion in 2021 to $636 billion by 2028, representing a CAGR of
over 32%. Galileo Life Sciences Inc. is thrilled to be a part of
this growth and contribute to the industry within its local market
and beyond. (source:fortunebusinessinsightt)
About Galileo Life Sciences Inc.
Galileo Life Sciences Inc. is a company strategically focused on
the telehealth and telemedicine industry. The company is dedicated
to offering the most robust telehealth platform incorporating AI
and IOT so that anyone can get access to quality healthcare
regardless of location and financial status. The company is
committed to providing healthcare to those who cannot afford it.
With the company's services, physicians can get direct access to
the patient's vitals and examine the patient in real-time without
affecting the quality of care.
Forward-looking Statements
This press release may contain information that may constitute
"forward-looking information" or "forward-looking statements"
within the meaning of applicable Canadian and U.S. securities laws
(collectively, "Forward-looking Statements"). All information
contained herein that is not clearly historical in nature may
constitute Forward-looking Statements. In some cases,
Forward-looking Statements can be identified by the use of
forward-looking terminology such as "may", "will", "expect",
"plan", "anticipate", "intend", "potential", "estimate", "believe"
or the negative of these terms, or other similar expressions
intended to identify Forward-looking Statements. There are no
guarantees or assurances that expansion in leadership will result
in the hopes the company has mentioned here. Any investment made
into Modern Mobility Aids, Inc., would be classified as speculative
and risky. Such risks and uncertainties include, but are not
limited to: market conditions, general acceptance of the company's
products and technologies, competitive factors, the ability to
successfully complete additional or adequate financing, government
approvals or changes to proposed laws, and other risks and
uncertainties further stated in the company's financial reports and
filings. Any Forward-looking Statement included in this press
release is made as of the date of this press release and, except as
required by law, Galileo Life Sciences Inc. and Modern Mobility
Aids Inc. disclaim any obligation to update or revise any
Forward-looking Statement. Readers are cautioned not to put undue
reliance on any Forward-looking Statement.
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Modern Mobility Aids (PK) (USOTC:MDRM)
Historical Stock Chart
From Nov 2023 to Nov 2024
